Seeking Alpha

Regeneron Pharma (REGN): Q4 EPS of $1.47 beats by $0.23. Revenue of $415M beats by $22.36M. (PR)

Regeneron Pharma (REGN): Q4 EPS of $1.47 beats by $0.23. Revenue of $415M beats by $22.36M. (PR)
Comments (1)
  • 31nottinham
    , contributor
    Comments (4) | Send Message
     
    This qt was a test, as patients moved from treatment every month to every other month, how would revenue growth be impacted, looks like REGN came through with flying colors
    14 Feb 2013, 08:00 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|